The Journal of Emergency Medicine
Volume 41, Issue 2 , Pages 166-171 , August 2011

Cardiac Arrest With Residual Blindness After Overdose of Tessalon® (Benzonatate) Perles

  • Victor Cohen, BS, PHARMD, BCPS, CGP

      Affiliations

    • Department of Pharmaceutical Services, Residency Training Program, Maimonides Medical Center, Brooklyn, New York
    • Corresponding Author InformationReprint Address: Victor Cohen, bs, pharmd, bcps, cgp, Department of Pharmaceutical Services, Maimonides Medical Center, 4802 Tenth Avenue, Brooklyn, NY 11219
    • ,
  • Samantha P. Jellinek, PHARMD, BCPS, CGP

      Affiliations

    • Department of Pharmaceutical Services, Residency Training Program, Maimonides Medical Center, Brooklyn, New York
    • ,
  • Lindsay Stansfield, PHARMD

      Affiliations

    • Department of Pharmaceutical Services, Residency Training Program, Maimonides Medical Center, Brooklyn, New York
    • ,
  • Henry Truong, MD

      Affiliations

    • Department of Emergency Medicine, Residency Training Program, Maimonides Medical Center, Brooklyn, New York
    • ,
  • Cindy Baseluos, MD

      Affiliations

    • Department of Emergency Medicine, Residency Training Program, Maimonides Medical Center, Brooklyn, New York
    • ,
  • John P. Marshall, MD

      Affiliations

    • Department of Emergency Medicine, Residency Training Program, Maimonides Medical Center, Brooklyn, New York

Received 22 May 2009 ,Revised 14 July 2009 ,Accepted 29 August 2009.

References 

  1. Homsi J, Walsh D, Nelson KA. Important drugs for cough in advanced cancer. Support Care Cancer. 2001;9:565–574
  2. Dicpinigaitis PV. Currently available antitussives. Pulm Pharmacol Ther. 2009;22:148–151
  3. Doona M, Walsh D. Benzonatate for opioid-resistant cough in advanced cancer. Palliat Med. 1997;12:55–58
  4. In:  Sweetman S editors. Martindale: The complete drug reference. London: Pharmaceutical Press; 2008;[electronic version] http://www.thomsonhc.com/hcs/librarian/ND_T/HCS/ND_PR/Main/CS/C8ED2C/DUPLICATIONSHIELDSYNC/38970B/ND_PG/PRIH/ND_B/HCS/SBK/1/ND_P/Main/PFActionId/hcs.common.RetrieveDocumentCommon/DocId/5605-j/ContentSetId/30/SearchTerm/tessalon/SearchOption/BeginWith
  5. Micromedex® Healthcare Series [Internet database]. Greenwood Village, CO: Thomson Healthcare http://www.thomsonhc.com/hcs/librarianAccessed May 22, 2009
  6. Tessalon®. [Package Insert] St. Louis, MO: Forest Pharmaceuticals Inc; 2003;
  7. Carolinas Poison Center. http://www.ncpoisoncenter.org/Educational/downloads/Benzonatate.pdfAccessed May 22, 2009
  8. Drug Topics. Top 200 generic drugs by retail dollars in 2007. [updated 2008] http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/102008/500218/article.pdfAccessed May 22, 2009
  9. Cohan JA, Manning TJ, Lukash L, Long C, Ziminski KR, Conradi SE. Two fatalities resulting from Tessalon (benzonatate). Vet Hum Toxicol. 1986;28:543–544
  10. Crouch BI, Knick KA, Crouch DJ, Matsumura KS, Rollins DE. Benzonatate overdose associated with seizures and arrhythmias. J Toxicol Clin Toxicol. 1998;36:713–718
  11. Shropshire A, Clifton J, Aks S, McAllister K, Draper P. Death from intentional IV administration of benzonatate. [abstract] J Toxicol Clin Toxicol. 1999;37:652
  12. Lewis-Younger C, Bizovi K. Arrhythmia and death in an adult associated with benzonatate. [abstract] J Toxicol Clin Toxicol. 2001;39:508
  13. Dunn EB, Nolte T, Wolfe JJ. Tessalon by the teaspoonful?. Hosp Pharm. 2001;36:1000–1002
  14. Litovitz TL, Klein-Schwartz W, Rodgers GC, et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2002;20:391–452
  15. Weber J, Scalzo A, Tabba M, Thompson M. Survival after recreational IV administration of benzonatate. [abstract] J Toxicol. 2003;41:745
  16. POISONDEX® Toxic Substances and Management, benzonatate. Greenwood Village, CO: Thomson Micromedex; c1974–2009 [cited 2009 Jan 14] http://www.thomsomhc.comAccessed May 22, 2009
  17. Balser JR. Structure and function of cardiac sodium channels. Cardiovasc Res. 1999;42:327–338
  18. Thoren P, Oberg B. Studies on the endoanesthetic effects of lidocaine and benzonatate on non-medullated nerve endings in the left ventricle. Acta Physiol Scand. 1981;111:51–58
  19. Lipid rescue resuscitation for cardiac toxicity. http://lipidrescue.squarespace.com/faqs/post/458903Accessed March 18, 2009
  20. BASF-The Chemical Company. Safety data sheet: Benzonatate. http://worldaccount.basf.com/wa/NAFTA∼en_US/Catalog/Pharma/doc4/BASF/PRD/30273578/Material%20Safety%20Data%20Sheet-US-EN.pdf?title=&asset_type=msds/pdf&language=EN&validArea=US&urn=urn:documentum:ProductBase_EU:09007af8800ec94e.pdfAccessed July 13, 2009
  21. Walmart.com Walmart $4 prescription program [updated 2008]. http://i.walmartimages.com/i/if/hmp/fusion/customer_list.pdfAccessed May 22, 2009
  22. Final rule issued on OTC cough medicines. FDA Consum. 1987;21:3
  23. Mitchell JF. Oral dosage forms that should not be crushed. [updated 2008] http://www.ismp.org/Tools/DoNotCrush.pdfAccessed May 22, 2009
  24. Benowitz NL. Anesthetics, local. In:  Olson KR editors. Poisoning & drug overdose. 4th edn.. New York: McGraw-Hill; 2003;p. 74–77

PII: S0736-4679(09)00752-5

doi: 10.1016/j.jemermed.2009.08.027

The Journal of Emergency Medicine
Volume 41, Issue 2 , Pages 166-171 , August 2011

Article Tools